4.6 Article

Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients

期刊

FRONTIERS IN MEDICINE
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2021.697338

关键词

COVID-19; acute respiratory distress syndrome; extracorporeal membrane oxygenation; extracorporeal life support (ECLS); respiratory failure

资金

  1. National Key Research and Development Project of the Ministry of Science and Technology, China [2018YFC1313700]
  2. Gaoyuan Project of Pudong Health and Family Planning Commission [PWYgy2018-6]
  3. Research Foundation of Shanghai Science and Technology Commission [18140904100]

向作者/读者索取更多资源

ECMO may be an effective treatment for critically ill patients with COVID-19, but careful patient selection and management by a trained team are crucial. More randomized controlled trials with larger sample sizes are needed to evaluate the actual effectiveness of ECMO in patients with COVID-19.
Covid-19, Coronavirus disease 2019; ARDS, Acute respiratory distress syndrome; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization; ICUs, Intensive care units. Acute respiratory distress syndrome (ARDS) is a fatal comorbidity of critically ill patients with COVID-19, who often end up on respiratory support. However, the safety and effectiveness of Extracorporeal Membrane Oxygenation (ECMO) in the treatment of COVID-19 remains to be elucidated at present. Here, we report on nine patients who received ECMO due to severe SARS-CoV-2 infection in Wuhan, China. Our initial experiences suggest that carefully selecting patients, as well as management by a well-trained team, are critical to implementing ECMO in patients with COVID-19. More randomized controlled trials with larger sample sizes are needed to evaluate the usefulness of ECMO in patients with COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据